Humanigen Announces Publication Demonstrating EphA3 Receptor as an Attractive Antibody Target for Brain Cancer and Other Solid Tumor Therapy in the Journal 'Cancers'
Stock Information for Humanigen Inc.
Loading
Please wait while we load your information from QuoteMedia.